Afyx Therapeutics A/S — Credit Rating and Financial Key Figures

Afyx Therapeutics A/S (CVR number: 38793594) is a company from HØRSHOLM. The company recorded a gross profit of 23.5 mDKK in 2024. The operating profit was -234 kDKK, while net earnings were -3810.6 kDKK. The profitability of the company measured by Return on Assets (ROA) was -11.7 %, which can be considered poor and Return on Equity (ROE) was -38.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 62.5 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Afyx Therapeutics A/S's liquidity measured by quick ratio was 2.2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.